Investigators stress the importance of ongoing research on the association between depression and pain in patients with sickle cell disease (SCD).
Employment status, age, sex, and depression are all linked with pain frequency among patients with sickle cell disease (SCD), findings from a cross-sectional analysis show.
Results were published in JAMA Network Open.
Pain is a key symptom of SCD and often contributes to increased health care utilization and hospitalizations, researchers explained. The pain these patients experience is also complex and does not occur in isolation, they added.
Previous research shows that SCD complications in patients are linked with social determinants of health, while family-level and neighborhood-level socioeconomic status can impact pain level, frequency, and patient quality of life.
What’s more, “mental health is related to opioid use for SCD-related pain and can be seen in stress and negative coping behaviors experienced by individuals with SCD,” the authors said. Patients with SCD also have depression rates approximately 3 times higher than the general population.
To better understand the association between pain episode frequency and severity among patients and factors like educational attainment, employment status, and mental health, the investigators recruited individuals from 8 clinical centers participating in the Sickle Cell Disease Implementation Consortium.
A total of 2264 patients with SCD were included in the study. All participants were aged 15 to 45 years. Patient registry data were collected between 2017 and 2018 and analyses were carried out between September 2020 and March 2022. The researchers assessed electronic medical records and findings from participant surveys. Of those included in the study, 56.2% were female.
The results show almost half of participants said they took a daily medication for pain and/or used hydroxyurea, just under 30% said they received regular blood transfusions, and 20% had received a diagnosis of depression.
Pain-specific measurements revealed 79.8% of patients had severe pain and 47.8% had more than 4 pain episodes in the past year.
Both educational attainment and income were not linked with increased pain frequency or severity, the researchers found. However, their analyses revealed several important findings:
Based on the findings, the researchers note “depression screening for these patients is warranted, especially among those experiencing higher pain frequency and severity.”
In addition, “comprehensive treatment and pain reduction must consider the full experiences of patients with SCD, including impacts on mental health,” they added.
The investigators also stressed the importance of the link between depression and pain episode frequency, as SCD has a disproportional impact on individuals of African descent. Black youth with SCD also tend to encounter stigma when they seek care for vaso-occlusive crises, a condition that can result in severe anemia and end-organ damage.
“Without proper screening and assessments for depression, we might overestimate other factors and overlook key factors or outcomes in this population,” the researchers concluded. “Further investigation is needed to both understand depression among this population and its association with SCD-related pain.”
Reference
Harris KM, Preiss L, Varughese T, et al. Examining mental health, education, employment, and pain in sickle cell disease. JAMA Netw Open. Published online May 18, 2023. doi:10.1001/jamanetworkopen.2023.14070
A new federal rule will enable thousands of immigrants in the Deferred Action for Childhood Arrivals (DACA) program to obtain health care through the Affordable Care Act; a forthcoming CMS rule is expected to lower home-based care wait times and raise caregiver wages; the HHS Office for Civil Rights has finalized 2 rules that strengthen the ACA’s health care discrimination ban.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Joanne Mizell: Lifestyle Modification Programs Take Holistic Aim at Metabolic Disease
May 1st 2024Joanne Mizell shares insurer strategies in addressing the escalating rates of metabolic diseases, highlighting the importance of holistic treatment methods like lifestyle modification programs, which integrate nutrition, physical activity, and community engagement.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Exagamglogene Autotemcel Shows Promise in Treatment of Transfusion-Dependent β-Thalassemia
April 30th 2024An ongoing, phase 3, open-label study demonstrated the efficacy of exagamglogene autotemcel (exa-cel) infusion to promote transfusion dependence in patients with transfusion-dependent β-thalassemia (TDT).
Read More
Health Equity and Access Weekly Roundup: April 27, 2024
April 27th 2024Racial disparities in end-of-life care, the role of wellness and faith in minority health, award-winning research on health disparities, societal factors impacting cardiometabolic health, and rising mental health challenges among US youth are all covered this week in the Center on Health Equity and Access.
Read More